Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage

Stroke

Volumn 30, Issue 6, 1999, Pages 1190-1195

  Wunderlich, Michael T ^a   Ebert, Anne D ^a   Kratz, Torsten ^a   Goertler, Michael ^a   Jost, Stefan ^a   Herrmann, Manfred ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Health status; Nerve tissue; Neuron specific enolase; Neuropsychology; Outcome; Protein S 100; Stroke

Indexed keywords

BIOCHEMICAL MARKER; NEURON SPECIFIC ENOLASE; PROTEIN S 100;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BRAIN INFARCTION; BRAIN INJURY; CONTROLLED STUDY; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; STROKE;

EID: 0032997273     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.30.6.1190     Document Type: Article

References (29)

1. Schäfer BW, Heizmann CW. The S100 family of EF-hand calcium-binding proteins: function and pathology. Trends Biochem Sci. 1996;21: 134-140.
2. Zimmer DB, Cornwall EH, Landar A, Song W. The S100 protein family: history, function, and expression. Brain Res Bull. 1995;37:417-429.
3. Marangos PJ. Neuron specific enolase: a clinically useful marker of neurons and neuroendocrine cells. Annu Rev Neurosci. 1987;10:269-295.
4. Barone FC, Clark RK, Price WJ, White RF, Feuerstein GZ, Storer BL, Ohlstein EH. Neuron-specific enolase increases in cerebral and systemic circulation following focal ischemia. Brain Res. 1993;623:77-82.
5. Abraha HD, Butterworth RJ, Bath PMW, Wassif WS, Garthwaite J, Sherwood RA. Serum S-100 protein: relationship to clinical outcome in acute stroke. Ann Clin Biochem. 1997;34:366-370.
6. Büttner T, Weyers S, Postert T, Sprengelmeyer R, Kuhn W. S-100 protein: serum marker of focal brain damage after ischemic territorial , MCA infarction. Stroke. 1997;28:1961-1965.
7. Butterworth RJ, Wassif WS, Sherwood RA, Gerges A, Poyser KH, Garthwaite J, Peters TJ, Bath PMW. Serum neuron-specific enolase, carnosinase, and their ratio in acute stroke. Stroke. 1996;27:2064-2068.
8. Cunningham RT, Watt M, Winder J, McKinstry S, Lawson JT, Johnston CF, Hawkins SA, Buchanan KD. Serum neurone-specific enolase as an indicator of stroke volume. Eur J Clin Invest. 1996;26:298-303.
9. Hårdemark HG, Ericsson N, Kotwica Z, Rundström G, Mendel-Hartvig I, Olsson Y, Påhlman S, Persson L. S-100 protein and neuron-specific enolase in CSF after experimental traumatic or focal ischemic brain damage. J Neurosurg. 1989;71:727-731.
10. Hatfield RH, McKernan RM. CSF neuron-specific enolase as a quantitative marker of neuronal damage in a rat model. Brain Res. 1992;577: 249-252.
11. Horn M, Seger F, Schlote W. Neuron-specific enolase in gerbil brain and serum after transient cerebral ischemia. Stroke. 1995;26:290-297.
12. Ingebrigtsen T, Romner B, Trumpy JH. Management of minor head injury: the value of early computed tomography and serum protein S-100 measurements. J Clin Neurosci. 1997;4:29-33.
13. Woertgen C, Rothoerl RD, Holzschuh M, Metz C, Brawanski A. Comparison of serial S-100 and NSE serum measurements after severe head injury. Acta Neurochir (Wien). 1997;139:1161-1165.
14. Hermann M, Curio N, Jost S, Wunderlich MT, Synowitz H, Wallesch CW. Protein S-100B and neuron specific enolase as early neurobiochemical markers of the severity of traumatic brain injury. Restor Neurol Neurosci. 1999;14:109-114.
15. Aberg T. Signs of brain cell injury during open heart operations: past and present. Ann Thorac Surg. 1995;59:1312-1315.
16. Blomquist S, Johnsson P, Lührs C, Malmkvist G, Solem JO, Ailing C, Stahl E. The appearance of S-100 protein in serum during and immediately after cardiopulmonary bypass surgery: a possible marker for cerebral injury. J Cardiothorac Vasc Anesth. 1997;11:699-703.
17. Rosén H, Rosengren L, Herlitz J, Blomstrand C. Increased serum levels of the S-100 protein are associated with hypoxic brain damage after cardiac arrest. Stroke. 1998;29:473-477.
18. Missler U, Wiesmann M, Friedrich C, Kaps M. S-100 protein and neuronspecific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke. 1997;28: 1956-1960.
19. Schaarschmidt H, Prange HW, Reiber H. Neuron-specific enolase concentrations in blood as a prognostic parameter in cerebrovascular diseases. Stroke. 1994;24:558-565.
20. Cunningham RT, Young IS, Winder J, O'Kane MJ, McKinstry S, Johnston CF, Dolan OM, Hawkins SA, Buchanan KD. Serum neuron specific enolase (NSE) levels as an indicator of neuronal damage in patients with cerebral infarction. Eur J Clin Invest. 1991; 21:497-500.
21. Fassbender K, Schmidt R, Schreiner A, Fatar M, Mühlhauser F, Daffertshofer M, Hennerici M. Leakage of brain-originated proteins in peripheral blood: temporal profile and diagnostic value in early ischemic stroke. J Neurol Sci. 1997;148:101-105.
22. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1999;337:1521-1526.
23. Adams HP, Bendixen BH, Kappelle J, Biller J, Love BB, Gordon DL, Marsh EE III, and the TOAST Investigators. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. Stroke. 1993;24:35-41.
24. Damasio H, Damasio AR. Lesion Analysis in Neuropsychology. New York, NY: Oxford University Press; 1989.
25. Matsui T, Hirano A. An Atlas of the Human Brain for Computerized Tomography. Stuttgart, Germany: Gustav Fischer Verlag; 1978.
26. Ghika JA, Bogousslavsky J, Regli F. Deep perforators from the carotid system: template of the vascular territories. Arch Neurol. 1990;47: 1097-1100.
27. Brott T, Adams HP, Olinger CP, Marier JR, Barsan WG, Biller J, Spilker J, Holleran R, Eberle R, Hertzberg V, Rorick M, Moomaw CJ, Walker M. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20:864-870.
28. Kim JS, Yoon SS, Kim YH, Ryu JS. Serial measurement of interleukin-6, transforming growth factor-β, and S-100 protein in patients with acute stroke. Stroke. 1996;27:1553-1557.
29. Aurell A, Rosengren LE, Karlsson B, Olsson JE, Zbornikova V, Haglid KG. Determination of S-100 and glial fibrillary acidic protein concentrations in cerebrospinal fluid after brain infarction. Stroke. 1991;22: 1254-1258.